慢性免疫介导炎症性疾病与心血管风险的关联
结果显示系统性结缔组织病、类风湿关节炎和炎症性肠病均增加心血管风险,抗炎治疗在各疾病中效应显著。
要点
- 系统性结缔组织病和类风湿关节炎心血管风险及人群影响最高。
- 炎症性肠病亦与心血管风险轻度增加相关。
- 抗炎治疗在所有疾病中均显示显著效应。
核心结论
- 系统性结缔组织病和类风湿关节炎 confer 最高的心血管风险和人群影响,其次为炎症性肠病。
主要发现
- 心血管病风险在系统性结缔组织病中模型1 HR=1.38(95%CI 1.21-1.57),模型2 HR=1.31(95%CI 1.15-1.49)。
- 类风湿关节炎模型1 HR=1.43(95%CI 1.26-1.62),模型2 HR=1.31(95%CI 1.15-1.49)。
- 炎症性肠病模型1 HR=1.18(95%CI 1.06-1.32),模型2 HR=1.12(95%CI 1.01-1.25)。
- 抗炎治疗效应显著,HR分别为1.50(95%CI 1.24-1.81)、1.47(95%CI 1.23-1.75)、1.43(95%CI 1.19-1.73)。
- 三种疾病的人群归因分数分别为13.4%、15.7%和10.7%。
临床怎么用
- 对系统性结缔组织病、类风湿关节炎和炎症性肠病患者应加强心血管风险评估与管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the association between chronic immune-mediated diseases (rheumatoid arthritis, systemic lupus erythematosus or the following chronic immune-mediated inflammatory diagnoses groups: inflammatory bowel diseases, inflammatory polyarthropathies, systemic connective tissue disorders and spondylopathies) and the 6-year coronary artery disease, stroke, cardiovascular disease incidence and overall mortality; and to estimate the population attributable fractions for all four end-points for each chronic immune-mediated inflammatory disease. METHODS: Cohort study of individuals aged 35-85 years, with no history of cardiovascular disease from Catalonia (Spain). The coded diagnoses of chronic immune-mediated diseases and cardiovascular diseases were ascertained and registered using validated codes, and date of death was obtained from administrative data. Cox regression models for each outcome according to exposure were fitted to estimate HRs in two models 1 : after adjustment for sex, age, cardiovascular risk factors and 2 further adjusted for drug use. Population attributable fractions were estimated for each exposure. RESULTS: Data were collected from 991 546 participants. The risk of cardiovascular disease was increased in systemic connective tissue disorders (model 1: HR=1.38 (95% CI 1.21 to 1.57) and model 2: HR=1.31 (95% CI 1.15 to 1.49)), rheumatoid arthritis (HR=1.43 (95% CI 1.26 to 1.62) and HR=1.31 (95% CI 1.15 to 1.49)) and inflammatory bowel diseases (HR=1.18 (95% CI 1.06 to 1.32) and HR=1.12 (95% CI 1.01 to 1.25)). The effect of anti-inflammatory treatment was significant in all instances (HR=1.50 (95% CI 1.24 to 1.81); HR=1.47 (95% CI 1.23 to 1.75); HR=1.43 (95% CI 1.19 to 1.73), respectively). The population attributable fractions for all three disorders were 13.4%, 15.7% and 10.7%, respectively. CONCLUSION: Systemic connective tissue disorders and rheumatoid arthritis conferred the highest cardiovascular risk and population impact, followed by inflammatory bowel diseases.
引用
- Baena-Díez JM, Garcia-Gil M, Comas-Cufí M, et al. Association between chronic immune-mediated inflammatory diseases and cardiovascular risk. Heart. 2017. PMID: 28847852. doi:10.1136/heartjnl-2017-311279
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。